Self-healing hydrogels loaded with Spatholobi Caulis alleviate disc degeneration by promoting autophagy in nucelus pulposus
Source abstract
Abstract
Intervertebral disc degeneration (IDD) is a common degenerative disease of the spine that has a significant impact on both society and human health. Many studies have confirmed that there is a close relationship between IDD and senescence and apoptosis, and autophagy can combat apoptosis and senescence. Spatholobi caulis (SC) is an herb that contains various active compounds that are effective in tissue repair and regeneration, but it has not been explored in field of IDD. In this study, it was first found that SC can boost autophagy and reduce the apoptosis and senescence of Nucleus pulposus cell (NPCs). However, our animal studies revealed limited absorption of SC. To improve the bioavailability and efficacy of SC, we developed a hydrogel incorporating quaternary ammonium chitosan (QCS) and oxidized starch (OST) as carriers for SC. The QCS-OST/SC hydrogel exhibits excellent compatibility with cells, can be easily injected, and can release SC durably. At the cellular level, the QCS-OST/SC hydrogel enhances cell viability, initiates autophagy and release of the extracellular matrix (ECM), and inhibits cellular senescence and apoptosis. The injection of the QCS-OST/SC hydrogel via microneedles (MNs) into discs had successfully diminished disc degeneration in rats, which shows that this hydrogel has broad potential in the treatment of IDD.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Spine and Intervertebral Disc Pathology · Wound Healing and Treatments · Hemostasis and retained surgical items
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. Intervertebral disc degeneration-Current therapeutic options and challenges10.3389/fpubh.2023.1156749 ↗
2. An update of current therapeutic approach for Intervertebral Disc Degeneration: a review article
3. Bradford DS: stimulation of mature canine intervertebral disc by growth factors10.1097/00007632-199103000-00001 ↗
4. Stem cell regeneration of degenerated intervertebral discs: current status10.1007/s11916-008-0016-3 ↗
5. Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma10.1186/s12985-024-02286-1 ↗
6. Extruded disc herniations are experienced earlier by inactive young people in the high-tech gaming era10.25122/jml-2021-1059 ↗
7. Surgical anatomy, radiological features, and molecular biology of the lumbar intervertebral discs10.1002/ca.22822 ↗
8. Nucleus pulposus cell-derived efficient microcarrier for intervertebral disc tissue engineering10.1088/1758-5090/acb572 ↗
9. Aging, cell senescence, the pathogenesis and targeted therapies of intervertebral disc degeneration
10. Role of autophagy in intervertebral disc degeneration10.1002/jcp.30631 ↗
11. Intervertebral disc cell fate during aging and degeneration: apoptosis, senescence, and autophagy
12. The dysregulated autophagy in osteoarthritis: revisiting molecular profile10.1016/j.pbiomolbio.2024.03.004 ↗
13. Sensitivity of substrate translocation in chaperone-mediated autophagy to Alzheimer's disease progression
14. Pharmacodynamic material basis and potential mechanism study of Spatholobi caulis in reversing osteoporosis10.1155/2023/3071147 ↗
15. Spatholobi Caulis extracts promote angiogenesis in HUVECs in vitro and in zebrafish embryos in vivo via up-regulation of VEGFRs10.1016/j.jep.2016.10.075 ↗
16. In vitro study on anti-hepatitis C virus activity of spatholobus suberectus dunn10.3390/molecules21101367 ↗
17. Effect of total flavonoids of Spatholobus suberectus Dunn on PCV2 induced oxidative stress in RAW264.7 cells10.1186/s12906-017-1764-6 ↗
18. Simultaneous determination of twenty-five compounds with anti-inflammatory activity in Spatholobi Caulis by using an optimized UFLC-MS/MS method: an application to pharmacokinetic study10.1016/j.jpba.2021.114267 ↗
19. Protective effects of Spatholobi caulis extract on neuronal damage and focal ischemic stroke/reperfusion injury10.1007/s12035-017-0652-x ↗
20. Caulis Spatholobi extracts inhibit osteosarcoma growth and metastasis through suppression of CXCR4/PI3K/AKT signaling10.1186/s13018-023-04437-6 ↗
21. Caulis Spatholobi ameliorates obesity through activating Brown adipose tissue and modulating the composition of gut microbiota
22. Biological analysis of constituents in Spatholobi Caulis by UFLC-MS/MS: enhanced quantification and application to permeability properties study in Caco-2 cell monolayer model10.1016/j.jpba.2023.115235 ↗
23. Preparation and properties of granular cold-water-soluble porous starch10.1016/j.ijbiomac.2019.12.060 ↗
24. Porous starch and its application in drug delivery systems10.17219/pim/99799 ↗
25. Starch-based hydrogels for environmental applications: a review10.1016/j.ijbiomac.2024.131956 ↗
26. Trends in polysaccharide-based hydrogels and their role in enhancing the bioavailability and bioactivity of phytocompounds10.1016/j.carbpol.2024.122033 ↗
27. Chitosan toughened epoxy resin by chemical cross-linking: enabling excellent mechanical properties and corrosion resistance
28. Bacterial growth-induced tobramycin smart release self-healing hydrogel for Pseudomonas aeruginosa-infected burn wound healing10.1021/acsnano.2c05557 ↗
29. In situ forming hydrogel of natural polysaccharides through Schiff base reaction for soft tissue adhesive and hemostasis10.1016/j.ijbiomac.2020.01.005 ↗
30. Injectable antibacterial conductive nanocomposite cryogels with rapid shape recovery for noncompressible hemorrhage and wound healing10.1038/s41467-018-04998-9 ↗
31. Engineering bioactive self-healing antibacterial exosomes hydrogel for promoting chronic diabetic wound healing and complete skin regeneration10.7150/thno.29766 ↗
32. Synthesis, spectral characterization, thermal investigation, computational studies, molecular docking, and in vitro biological activities of a new Schiff base derived from 2-chloro benzaldehyde and 3,3'-Dimethyl-[1,1'-biphenyl]-4,4'-diamine10.1021/acsomega.3c05254 ↗
33. What is intervertebral disc degeneration, and what causes it?10.1097/01.brs.0000231761.73859.2c ↗
34. The roles of circRNAs in intervertebral disc degeneration: inflammation, extracellular matrix metabolism, and apoptosis10.1155/2022/9550499 ↗
35. Cellular senescence in intervertebral disc aging and degeneration: molecular mechanisms and potential therapeutic opportunities10.3390/biom13040686 ↗
36. Review: autophagy in neurodegeneration: firefighter and/or incendiarist?10.1111/j.1365-2990.2009.01034.x ↗
37. Autophagy and inflammation in chronic respiratory disease10.1080/15548627.2017.1389823 ↗
38. The dual role of autophagy in chondrocyte responses in the pathogenesis of articular cartilage degeneration in osteoarthritis10.3892/ijmm.2013.1520 ↗
39. Stimulation of autophagy promotes functional recovery in diabetic rats with spinal cord injury10.1038/srep17130 ↗
40. Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo10.1038/cddis.2016.334 ↗
41. NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration10.1111/cpr.13057 ↗
42. HOXC13-AS induced extracellular matrix loss via targeting miR-497-5p/ADAMTS5 in intervertebral disc10.3389/fmolb.2021.643997 ↗
43. DAPK1: a novel pathology and treatment target for Alzheimer's disease10.1007/s12035-018-1242-2 ↗
44. Dapk1 improves inflammation, oxidative stress and autophagy in LPS-induced acute lung injury via p38MAPK/NF-κB signaling pathway10.1016/j.molimm.2020.01.014 ↗
45. Death associated protein kinase 1 (DAPK1): a regulator of apoptosis and autophagy10.3389/fnmol.2016.00046 ↗
46. Designing hydrogels for on-demand therapy10.1021/acs.accounts.6b00536 ↗
47. A pH- and temperature-responsive bioresorbable injectable hydrogel based on polypeptide block copolymers for the sustained delivery of proteins in vivo10.1039/C7BM00980A ↗
48. Polyethylene glycol (PEG)-Poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications10.1016/j.ejpb.2014.07.005 ↗
49. Gel/hydrogel-based in situ biomaterial platforms for cancer postoperative treatment and recovery
50. Biological tolerance of ionogenic hydrophilic gels10.1002/jbm.820070110 ↗
51. Injectable self-healing hydrogel with siRNA delivery property for sustained STING silencing and enhanced therapy of intervertebral disc degeneration
52. Starch-based hydrogels as a drug delivery system in biomedical applications10.3390/gels9120951 ↗
53. [Effect of basic fibroblast growth factor and transforming growth factor-β1 combined with bone marrow mesenchymal stem cells on the repair of degenerated intervertebral discs in rat models
54. Differential regulation of matrix degrading enzymes in a TNFalpha-induced model of nucleus pulposus tissue degeneration10.1016/j.matbio.2006.07.002 ↗
55. Naringin inhibits apoptosis induced by cyclic stretch in rat annular cells and partially attenuates disc degeneration by inhibiting the ROS/NF-κB pathway
56. Proteomic comparison between physiological degeneration and needle puncture model of disc generation disease10.1007/s00586-022-07284-x ↗
57. A minimally invasive annulus fibrosus needle puncture model of intervertebral disc degeneration in rats10.1016/j.wneu.2022.09.062 ↗
58. Experimental model of intervertebral disc degeneration by needle puncture in Wistar rats10.1590/1414-431X20122429 ↗
59. Effectivity of puncture method for intervertebral disc degeneration animal models: review article10.1097/MS9.0000000000000829 ↗
60. Rat tail models for the assessment of injectable nucleus pulposus regeneration strategies10.1002/jsp2.1216 ↗
61. Serglycin secreted by late-stage nucleus pulposus cells is a biomarker of intervertebral disc degeneration10.1038/s41467-023-44313-9 ↗